Thalys Medical Technology Group Corporation (SHA:603716)

China flag China · Delayed Price · Currency is CNY
23.56
-0.34 (-1.42%)
Mar 10, 2026, 9:45 AM CST
136.07%
Market Cap 4.93B
Revenue (ttm) 1.25B
Net Income (ttm) -240.46M
Shares Out 206.22M
EPS (ttm) -1.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,696,498
Average Volume 9,761,168
Open 23.66
Previous Close 23.90
Day's Range 23.30 - 23.85
52-Week Range 8.10 - 38.12
Beta 0.83
RSI 58.59
Earnings Date Apr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Sector Healthcare
Founded 2004
Employees 1,246
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603716
Full Company Profile

Financial Performance

In 2024, SHA:603716's revenue was 1.81 billion, a decrease of -9.74% compared to the previous year's 2.01 billion. Losses were -209.24 million, 32.0% more than in 2023.

Financial Statements

News

There is no news available yet.